Philip Wenzel Selected Research

Fibrosis (Cirrhosis)

1/2020	Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
8/2019	Potential Involvement of Osteopontin in Inflammatory and Fibrotic Processes in Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension.
1/2019	T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of ·NO/cGMP Signaling.
1/2019	Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.
1/2017	Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.
2/2015	Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip Wenzel Research Topics

Disease

29	Inflammation (Inflammations) 11/2022 - 03/2011
21	Hypertension (High Blood Pressure) 01/2020 - 10/2006
10	Thrombosis (Thrombus) 12/2021 - 11/2013
9	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 12/2014
9	Myocardial Infarction 03/2021 - 07/2009
8	Cardiovascular Diseases (Cardiovascular Disease) 07/2020 - 07/2009
7	Skin Diseases (Skin Disease) 11/2022 - 12/2014
7	Heart Failure 03/2021 - 08/2007
7	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 01/2014
6	Fibrosis (Cirrhosis) 01/2020 - 02/2015
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 07/2009
5	Diabetes Mellitus 12/2015 - 05/2008
4	Cardiotoxicity 01/2020 - 08/2007
4	Atherosclerosis 01/2020 - 11/2013
4	Body Weight (Weight, Body) 01/2017 - 09/2008
3	Neoplasms (Cancer) 01/2022 - 09/2020
3	Hemorrhage 01/2022 - 01/2017
3	Myocarditis (Carditis) 01/2022 - 08/2007
3	Acute Coronary Syndrome 11/2020 - 01/2014
3	Cardiomegaly (Heart Hypertrophy) 01/2020 - 02/2015
3	Cardiomyopathies (Cardiomyopathy) 01/2019 - 08/2007
3	Vascular Diseases (Vascular Disease) 01/2019 - 11/2011
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2014 - 11/2011
2	Chest Pain (Chest Pains) 01/2021 - 11/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 10/2017
2	Necrosis 11/2019 - 12/2018
2	Pulmonary Hypertension 08/2019 - 01/2017
2	Pulmonary Embolism 08/2019 - 01/2018
2	Alcoholic Cardiomyopathy 01/2018 - 01/2016
2	Hyperlipidemias (Hyperlipidemia) 10/2017 - 11/2006
2	Ischemia 07/2015 - 04/2011
2	Hyperglycemia 01/2014 - 10/2011
2	Vascular System Injuries 01/2014 - 09/2008
2	Infarction (Infarctions) 04/2011 - 07/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2011 - 09/2008
1	Hypertrophy 10/2022
1	Muscular Diseases (Myopathy) 10/2022

Drug/Important Bio-Agent (IBA)

21	Angiotensin IIIBA 10/2022 - 10/2006
10	CytokinesIBA 01/2020 - 08/2007
9	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2017 - 11/2006
7	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018 - 10/2006
7	NitratesIBA 11/2015 - 08/2008
6	Superoxides (Superoxide)IBA 03/2021 - 12/2005
5	Messenger RNA (mRNA)IBA 06/2022 - 02/2015
5	Interleukin-17 (Interleukin 17)IBA 01/2022 - 12/2014
5	Pharmaceutical PreparationsIBA 11/2021 - 01/2014
5	NitrogenIBA 01/2017 - 01/2011
5	Oxygen (Dioxygen)IBA 01/2017 - 01/2011
5	EnzymesIBA 02/2014 - 09/2008
4	Thrombin FDA Link 09/2020 - 01/2017
4	Muramidase (Lysozyme)IBA 11/2019 - 09/2011
4	ChemokinesIBA 01/2019 - 08/2007
4	Pentaerythritol Tetranitrate (Pentalog)IBA 01/2017 - 02/2010
4	Heme Oxygenase-1IBA 12/2015 - 08/2010
4	Streptozocin (Streptozotocin)FDA Link 12/2015 - 05/2008
4	AntioxidantsIBA 01/2014 - 09/2008
4	Nitroglycerin (Dynamite)FDA LinkGeneric 07/2009 - 11/2006
3	Imiquimod (Aldara)FDA LinkGeneric 11/2022 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 08/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 01/2015
3	Interferon-gamma (Interferon, gamma)IBA 11/2019 - 08/2007
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2006
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 01/2014
3	Interleukin-12 (IL 12)IBA 01/2018 - 08/2007
3	InterferonsIBA 12/2016 - 08/2007
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 05/2008
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2020
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 08/2019
2	AnticoagulantsIBA 09/2020 - 01/2017
2	Liraglutide FDA Link 01/2020 - 01/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2017
2	InterleukinsIBA 08/2019 - 12/2014
2	Telmisartan (Micardis)FDA Link 08/2019 - 09/2008
2	FibrinIBA 01/2019 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 02/2015
2	AcetaldehydeIBA 01/2018 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 10/2012
2	Thromboplastin (Tissue Factor)IBA 01/2017 - 01/2017
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 01/2016
2	LinagliptinIBA 01/2017 - 10/2012
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2016 - 09/2011
2	Peroxidase (Myeloperoxidase)IBA 07/2015 - 12/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 02/2014 - 11/2006
2	IvabradineIBA 11/2011 - 10/2009
2	acetovanillone (apocynin)IBA 03/2011 - 01/2011
2	Blood Glucose (Blood Sugar)IBA 01/2011 - 09/2008
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2011 - 04/2009
2	Atorvastatin (Lipitor)FDA Link 07/2009 - 05/2008
1	CalnexinIBA 10/2022
1	Beclin-1IBA 10/2022
1	ursodoxicoltaurineIBA 10/2022
1	Mitochondrial Permeability Transition PoreIBA 10/2022
1	Hormones (Hormone)IBA 10/2022
1	CalciumIBA 10/2022
1	VaccinesIBA 06/2022

Therapy/Procedure

7	Therapeutics 09/2020 - 09/2008
6	Ligation 12/2021 - 01/2014
3	Percutaneous Coronary Intervention 01/2020 - 11/2017
3	Stents 11/2017 - 01/2014